Article
Requirement of the NF-κB Subunit p65/RelA for K-Ras–Induced Lung Tumorigenesis
21 Apr 2010
Abstract excerpt
K-Ras-induced lung cancer is a very common disease, for which there are currently no effective therapies. Because therapy directly targeting the activity of oncogenic Ras has been unsuccessful, a different approach for novel therapy design is to identify critical Ras downstream oncogenic targets. Given that oncogenic Ras proteins activate the transcription factor NF-kappaB, and the importance of NF-kappaB in...
Topics
Join the communities discussing this publication.
